Hextend Injection, Solution
Product Images NDC 0409-1555

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hextend (NDC 0409-1555). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hextend 01

Chemical structure diagram of hetastarch showing the cyclic glucose units with various substituent groups, representing the polysaccharide polymer backbone of this intravenous injection solution.*

FDA Label Image

Hextend 02

FDA Label Image

Hextend 03

Label for Hextend 6% Hetastarch in Lactated Electrolyte Injection, an intravenous solution in a 500 mL bag. The label includes detailed ingredient information and usage instructions. Distributed by Hospira, Inc., it displays the NDC 0409-1555-64 and contains a barcode. The bag has dual ports at the bottom for administration.*

FDA Label Image

Hextend 04

A drug label panel providing instructions titled 'TO OPEN TEAR AT NOTCH.' It advises not to remove from overwrap until ready for use, checking for leaks after removing overwrap, discarding if leaks are found, and recommended storage at room temperature (25°C). It notes the product is not made with natural rubber latex and includes a recycling symbol with 'HDPE.' Several areas are marked 'NO COPY NO INK.'*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.